ICON plc is a world-leading healthcare intelligence and clinical research organization. We’re proud to foster an inclusive environment driving innovation and excellence, and we welcome you to join us on our mission to shape the future of clinical development.
ICON plc is a world-leading healthcare intelligence and clinical research organization. We’re proud to foster an inclusive environment driving innovation and excellence, and we welcome you to join us on our mission to shape the future of clinical development. The Study Start Up Manager is accountable for study planning, Study Start Up activities and activation deliverables of assigned projects. Responsible for GCP/ICH and regulatory requirements in a stand alone country. The SSU managaer will lead all SSU activities of assigned projects in close collaboration with SSO Feasibility Manager and SSO Site Partnership Manager as well as the global Study team.
ICON plc is a world-leading healthcare intelligence and clinical research organization. We’re proud to foster an inclusive environment driving innovation and excellence, and we welcome you to join us on our mission to shape the future of clinical development.
The Clinical Research Associate will perform site activities for Phase I-IV studies operating as the main point of contact for the site during a study. Drive and execute monitoring plans, ensure site GCP compliance, write trip reports, resolve issues and facilitate open issue resolution, work on recruitment strategies, and monitor safety at the site. The CRA will conduct site qualification visits as assigned, site initiation visits and site training, routine monitoring visits, and site close-out visits. Perform investigator site management activities in adherence to all applicable regulatory guidelines and standard operating procedures (SOPs).
ICON plc is a world-leading healthcare intelligence and clinical research organization. We’re proud to foster an inclusive environment driving innovation and excellence, and we welcome you to join us on our mission to shape the future of clinical development.